David Kavanagh, MBChB, PhD: Iptacopan Offers Hope for C3 Glo

A Q&A with David Kavanagh, MBChB, PhD, on the results of the APPEAR-C3G trial and implications for care moving forward.

Related Keywords

Stockholm , Sweden , David Kavanagh , European Renal Association Congress , Faculty Of Medical Sciences At Newcastle University , Foundation Trust David Kavanagh , Novartis , Complement Therapeutics , Honorary Consultant Nephrologist , Medical Sciences , European Renal Association ,